TREAT FIRST – HCV Treatment and Care at Syringe Access Sites

Module number
 
Date presented
January 15, 2018 
Duration
49:53 
Audience
 
CE Credit
 

On Tuesday, January 15th, Dr. Pierre-Cedric Crouch and Pauli Gray of the San Francisco AIDS Foundation presented on: “TREAT FIRST – HCV Treatment and Care at Syringe Access Sites”

About Dr. Crouch:
Pierre is the Director of Nursing at Magnet, a community-based arm of the San Francisco AIDS Foundation that delivers sexual health services to gay, bi, and transmasculine communities in the San Francisco Bay Area. He grew up in New Orleans, Louisiana where he obtained his BSN from the Louisiana State University Health Science Center. He had an early passion for HIV care and technology, which lead him to move to San Francisco, where he received his MSN (Nurse Practitioner) and PhD from the University of California, San Francisco. He went on to develop and implement on of the largest nurse-led PrEP Health Program, which has garnered world-wide recognition. He geeks out over technologies that connect clients to their health and the development of RN-delivered community-based care. He leads in Health Care 3.0, which supports nurses practicing to the fullest extent of their license and taking a client-centered approach to remove traditional barriers to accessing health care. He is currently working on expanding anal health services, implementing full point of care STI testing, and developing a nurse-led community-based hepatitis C treatment program.

About Mr. Gray:
Pauli Gray has been doing Harm Reduction work with several specialties for 19 years, and Hep C work since 2002. Mr. Gray has done more than 600 Trainings and Speaking events on Hep C, OD Prevention, HIV, Needle Exchange and Harm Reduction, on three continents, from San Francisco to Africa. Besides being the Senior HCV Coordinator and Harm Reduction Specialist at the San Francisco AIDS Foundation for the Syringe Access Services program, Mr. Gray also is a member of the End Hep C Coordinating Committee, Treatment Access, Testing and Linkage Groups, and the Hep C Task Force.

Access the slides here

Supporting Document: Magnet Clinical Protocols